Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome

“Humoral autoimmunity may contribute to cognitive impairment in post-COVID-19 syndrome”.

The majority of Long COVID patients with cognitive impairment may have CNS autoantibodies as reported in a study led by Charité – Universitätsmedizin Berlin and published recently in “Brain, Behavior, and Immunity“.

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome – ScienceDirect